2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate-D7; (11?,16?)-16,17-[[(R)-Cyclohexyl-methylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy-d7)-pregna-1,4-diene-3,20-dione; Alvesco-d7; Omnaris-d7; RPR 251526-d7
Ciclesonide-d7 is a fully characterized chemical compound used as a reference standard of API Ciclesonide. The standard offered is compliant with regulatory guidelines. Ciclesonide-d7 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1225382-70-6
